Peregrine Asset Advisers’s Boston Scientific BSX Stock Holding History

Peregrine Asset Advisers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-96,330	Closed	-$1.23M	–	122
2014 Q2	$1.23M	Sell	96,330 -500	-0.5%	-$6.5K	1.11%	29
2014 Q1	$1.31M	Buy	96,830 +850	+0.9%	+$11.2K	1.01%	32
2013 Q4	$1.15M	Sell	95,980 -7,740	-7%	-$91.4K	1.01%	28
2013 Q3	$1.22M	Buy	+103,720	New	+$1.12M	1.17%	23

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Peregrine Asset Advisers's BSX Position: Q3 2014 in Review

Peregrine Asset Advisers sold out of Boston Scientific (BSX) in Q3 2014, closing a stake of 96,330 shares — an estimated $1.23M sold.

Peregrine Asset Advisers first reported a position in BSX in Q3 2013 and held it in 4 quarters. The position peaked at $1.31M in Q1 2014. 437 funds tracked by Wall St. Rank hold BSX as of Q3 2014.

Peregrine Asset Advisers reported no remaining Boston Scientific position as of Q3 2014 after selling out during the quarter.
Peregrine Asset Advisers sold 96,330 Boston Scientific shares in Q3 2014, an estimated $1.23M.
Peregrine Asset Advisers first reported a position in Boston Scientific in Q3 2013 and held it in 4 quarters.
Peregrine Asset Advisers's Boston Scientific position peaked at $1.31M in Q1 2014.
437 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2014.

Based on Peregrine Asset Advisers's 13F filing for Q3 2014, filed 13 Nov 2014.